Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 40, 2011 - Issue 5
Submit an article Journal homepage
303
Views
21
CrossRef citations to date
0
Altmetric
Articles

Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus

L HopiaDivision of Neurology, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden;Department of Clinical Neuroscience, Neuroimmunology Unit, Centre for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden
,
M ThangarajhDivision of Neurology, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden
,
M KhademiDepartment of Clinical Neuroscience, Neuroimmunology Unit, Centre for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden
,
A LaveskogDivision of Neuroradiology, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden, Stockholm, Sweden
,
E WallströmDivision of Neurology, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden;Department of Clinical Neuroscience, Neuroimmunology Unit, Centre for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden
,
E SvenungssonDepartment of Medicine, Unit of Rheumatology, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden
&
M AnderssonDivision of Neurology, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, Sweden;Department of Clinical Neuroscience, Neuroimmunology Unit, Centre for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital (Solna), Stockholm, SwedenCorrespondence[email protected]
 show all
Pages 363-372 | Accepted 22 Dec 2011, Published online: 18 May 2011

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Huihua Ding, Yiwei Shen, Soon-Min Hong, Chunyan Xiang & Nan Shen. (2023) Biomarkers for systemic lupus erythematosus – a focus on organ damage. Expert Review of Clinical Immunology 0:0, pages 1-20.
Read now
Y Xu, D Xu, T Zhang, X-M Leng, F-C Zhang & X-F Zeng. (2012) The prevalence and clinical characteristics of systemic lupus erythematosus with infectious brain lesions in China. Scandinavian Journal of Rheumatology 41:6, pages 466-471.
Read now

Articles from other publishers (19)

Leonardo Palazzo, Julius Lindblom, Nursen Cetrez, Henri Ala & Ioannis Parodis. (2023) Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab. Rheumatology.
Crossref
Jonathan S. Emerson, Simon M. Gruenewald, Lavier Gomes, Ming-Wei Lin & Sanjay Swaminathan. (2023) The conundrum of neuropsychiatric systemic lupus erythematosus: Current and novel approaches to diagnosis. Frontiers in Neurology 14.
Crossref
Yidan Zhang, Jie Tian, Fan Xiao, Leting Zheng, Xiaoxia Zhu, Ling Wu, Cheng Zhao, Shengjun Wang, Ke Rui, Hejian Zou & Liwei Lu. (2022) B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews 64, pages 57-70.
Crossref
Julius Lindblom, Chandra Mohan & Ioannis Parodis. (2022) Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade. Brain Sciences 12:2, pages 192.
Crossref
Kiarash Saleki, Moein Shirzad, Mohammad Banazadeh, Mohamad Hosein Mohamadi, Parsa Alijanizadeh, Nima Javanmehr, Ramtin Pourahmad, Mahdi Shakeri, Reza Nikkhoo Amiri, Payam Payandeh & Payam Saadat. 2022. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title]. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title].
Hao Cheng, Chen-sheng Zhao, Cheng-lan Yan, Chong Gao & Hong-yan Wen. (2021) Efficacy of Belimumab for refractory systemic lupus erythematosus (SLE) involving the central nervous system. European Journal of Internal Medicine 92, pages 117-120.
Crossref
Fabio Basta, Tamara Möckel, Jan Petersohn, Myriam Meineck, Konstantinos Triantafyllias, Sinah Engel, Arndt Weinmann, Felix Luessi, Julia Weinmann-Menke & Andreas Schwarting. (2021) The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosis. Autoimmunity Reviews 20:5, pages 102802.
Crossref
Ariane Barbacki, Michelle Petri, Antonio Aviña-Zubieta, Graciela S. Alarcón & Sasha Bernatsky. (2019) Fatigue Measurements in Systemic Lupus Erythematosus. The Journal of Rheumatology 46:11, pages 1470-1477.
Crossref
Nancy P. Duarte-Delgado, Gloria Vásquez & Blanca L. Ortiz-Reyes. (2019) Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. Autoimmunity Reviews 18:4, pages 426-432.
Crossref
Miyako Baba, Kunihiro Ichinose, Mami Tamai, Atsushi Kawakami & Kaname Ohyama. (2018) Similarity of autoimmune diseases based on the profile of immune complex antigens. Rheumatology International 39:2, pages 323-325.
Crossref
Taku Yoshio & Hiroshi Okamoto. 2018. Neuropsychiatric Systemic Lupus Erythematosus. Neuropsychiatric Systemic Lupus Erythematosus 155 168 .
Paula Gyllemark, Pia Forsberg, Jan Ernerudh & Anna J. Henningsson. (2017) Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study. Journal of Neuroinflammation 14:1.
Crossref
César Magro-Checa, Elisabeth J. Zirkzee, Tom W. Huizinga & Gerda M. Steup-Beekman. (2016) Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs 76:4, pages 459-483.
Crossref
J T Merrill, R F van Vollenhoven, J P Buyon, R A Furie, W Stohl, M Morgan-Cox, C Dickson, P W Anderson, C Lee, P-Y Berclaz & T Dörner. (2016) Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases 75:2, pages 332-340.
Crossref
Kavitha Kothur, Louise Wienholt, Fabienne Brilot & Russell C. Dale. (2016) CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. Cytokine 77, pages 227-237.
Crossref
Barbara Stypińska & Agnieszka Paradowska-Gorycka. (2015) Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus. International Journal of Molecular Sciences 16:10, pages 24194-24218.
Crossref
Sen Tay & Anselm Mak. (2015) Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus. International Journal of Molecular Sciences 16:12, pages 10281-10300.
Crossref
Kunihiro Ichinose, Kazuhiko Arima, Takeshi Ushigusa, Ayako Nishino, Yoshikazu Nakashima, Takahisa Suzuki, Yoshiro Horai, Hideki Nakajima, Shin-ya Kawashiri, Naoki Iwamoto, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masakatsu Motomura & Atsushi Kawakami. (2015) Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases. Clinical Immunology 157:2, pages 114-120.
Crossref
Michael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, Anna L Travelstead, Jerry A Colliver, Jayne M Ness & Richard M Ransohoff. (2013) BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. Journal of Neuroinflammation 10:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.